“IMP-1 Inhibits Renal Cell Carcinoma 786-O Cell Growth by Targeting EphrinB2 Signaling Pathway”. Brazilian Journal of Pharmaceutical Sciences 59 (junho 22, 2023). Acessado maio 17, 2024. https://periodicos.usp.br/bjps/article/view/213468.